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ABSTRACT Tristetraprolin (TTP) is a tandem CCCH zinc ﬁnger protein that can bind
to AU-rich element-containing mRNAs and promote their decay. TTP knockout mice
develop a severe inﬂammatory syndrome, largely due to excess tumor necrosis fac-
tor (TNF), whose mRNA is a direct target of TTP binding and destabilization. TTP’s
RNA binding activity and its ability to promote mRNA decay are lost when one of
the zinc-coordinating residues of either zinc ﬁnger is mutated. To address several
long-standing questions about TTP activity in intact animals, we developed a knock-in
mouse with a cysteine-to-arginine mutation within the ﬁrst zinc ﬁnger. Homozygous
knock-in mice developed a severe inﬂammatory syndrome that was essentially iden-
tical to that of complete TTP deﬁciency, suggesting that TTP’s critical anti-inﬂam-
matory role in mammalian physiology is secondary to its ability to bind RNA. In addi-
tion, there was no evidence for a “dominant-negative” effect of the mutant allele in
heterozygotes, as suggested by previous experiments. Finally, mRNA decay experiments
in mutant macrophages demonstrated that TTP can regulate the stability of its own
mRNA, albeit to a minor extent. These studies suggest that RNA binding is an essential
ﬁrst step in the physiological activities of members of this protein family.
KEYWORDS AU-rich elements, RNA binding proteins, inﬂammation, mRNA decay,
zinc ﬁnger proteins
Regulation of gene expression by control of mRNA stability is a critical focus ofcontrol and one that can be modulated by cellular RNA binding proteins (1, 2).
Many proteins have been identiﬁed that can bind directly to transcripts, in some cases
with sequence speciﬁcity and high afﬁnity, leading to either protection of the mRNA
from decay or promotion of degradation (2, 3) An example of the latter category is the
tristetraprolin (TTP) family of CCCH tandem zinc ﬁnger (TZF) proteins. In the mouse, this
family consists of four proteins with markedly different patterns of tissue-speciﬁc and
developmental stage expression (4–8); however, in cell transfection studies, all four
proteins seem to behave similarly in terms of regulating mRNA stability (9, 10).
The role of TTP as an mRNA-destabilizing and mRNA binding protein was ﬁrst
recognized after development of a TTP knockout (KO) mouse (11, 12). These animals
developed a characteristic syndrome of failure to gain weight accompanied by loss of
body fat, severe peripheral polyarthritis, myeloid hyperplasia, and autoimmunity. Since
this syndrome resembled previous models of excess tumor necrosis factor alpha (TNF)
(13, 14), we tested the hypothesis that excess TNF was involved in its development. The
weekly administration of anti-TNF antibodies to KO mice shortly after birth largely
prevented the development of the KO phenotype (11). In addition, TTP knockout mice
interbred with mice deﬁcient in both types of TNF receptor developed essentially none
of the characteristics of the TTP KO phenotype (15). Both of these studies demonstrated
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that a chronic effective excess of TNF was playing a major pathogenetic role in the
development of the TTP deﬁciency phenotype.
We then showed that macrophages derived from the TTP KO mice secreted more
TNF than control cells in response to lipopolysaccharide (LPS) and that this was
associated with commensurate increases in TNF mRNA levels in the knockout cells (12).
These increased mRNA levels were found to be largely due to stabilization of the TNF
mRNA in the TTP KO macrophages (12). We ultimately found that TTP, through its TZF
domain, could bind directly to the 3= untranslated region (3=UTR) of the TNF mRNA and
that this started a chain of events resulting in the deadenylation of the mRNA and its
ultimate destruction (12, 16).
The ideal binding sequence for the TTP TZF domain in mRNA was UUAUUUAUU, a
sequence that is repeated several times within the TNF AU-rich element (ARE); most of
these 9-mers are highly conserved among mammalian TNF mRNAs (17). When synthetic
peptides comprising the TTP TZF domain were used in RNA binding assays with
puriﬁed components, the Kd (dissociation constant) of the TTP TZF domain peptide to
the optimal mRNA 9-mer was approximately 3 nM at room temperature (18). A
structure of the TZF domain from the TTP family member ZFP36L2 (Tis11d) in complex
with this same 9-mer was analyzed by Wright and colleagues (19). Major protein-RNA
interactions included stacking interactions between the RNA bases and aromatic rings
of conserved hydrophobic amino acids within or leading into the tandem zinc ﬁnger
domains, as well as electrostatic interactions. Strikingly, the RNA binding site was
unstructured in this complex (19), suggesting that secondary structure of the mRNA
might be deleterious to protein binding.
One important ﬁnding from the RNA binding studies was that mutation of any one
of the eight cysteines and histidines within the TZF domain completely abrogated
high-afﬁnity RNA binding (20), even when the other ﬁnger remained intact. When point
mutants of this type, as well as those with several other nonbinding mutations within
the TZF domain, were used in cotransfection assays of TTP activity to promote the
decay of TNF, granulocyte-macrophage colony-stimulating factor (GM-CSF), and
interleukin-3 (IL-3) transcripts, we found severalfold-increased accumulation of the
target transcripts compared to the starting levels (16, 20). These data suggested that
the mutant proteins were having a deleterious effect on the target mRNA degradation
machinery, possibly by interfering with protein factors involved in mRNA decay.
These ﬁndings suggested the possibility that a similar mutant form of TTP could
exert a “dominant-negative” effect in intact animals. To test this idea, we have made the
analogous mutation using knock-in (KI) technology in the mouse, allowing us to
determine whether the mutant allele had a dominant-negative effect on the wild-type
(WT) allele. These mice, and cells derived from them, also allowed us to address several
other long-standing questions concerning TTP activity: (i) whether all of TTP’s physio-
logical effects stem from its initial RNA binding ability, (ii) whether TTP can regulate the
stability of its own mRNA, and (iii) whether the effect of TTP to promote the decay of
its target mRNAs is a transient effect that occurs only immediately after its induction or
can be sustained for several hours after its initial synthesis.
RESULTS
Nature of the C116R mutation. We introduced a T-to-C substitution in exon 2 of
the Zfp36 locus, encoding TTP, in an attempt to create a mouse that would express the
TTP protein with a mutated zinc-coordinating residue in one of its TZF domains, as
shown in the scheme in Fig. 1A. The tandem zinc ﬁnger (TZF) domain of mouse TTP is
illustrated in Fig. 1B, which shows the location of the cysteine-to-arginine (C116R)
mutation in the third cysteine of the ﬁrst zinc ﬁnger. This was accomplished by
mutating a single T to C in the cysteine codon (Fig. 1A). Similar to results obtained with
the human TTP protein with the analogous mutation (Fig. 1D, lanes 3 and 4), when this
mutant protein was used in RNA gel shift analyses, the binding of the full-length
mutant TTP protein to a TNF-based RNA probe was completely abrogated (lanes 5 and
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6). Expression in 293 cells of WT and mutant human and mouse proteins is documented
in Fig. 1E.
For the analyses of TTP’s effect on the stability of its own mRNA described below, it
is important to note that the WT and mutant mRNAs should be identical except for the
single T-to-C change at bp 377 in the sequence under GenBank accession no.
NM_011756.4. Since the mutant gene remained in its endogenous Zfp36 locus, all other
aspects of Zfp36 expression should be the same in these two lines of mice.
FIG 1 Scheme of Zfp36 gene targeting and the TZF domain mutant. (A) Schematic representation of the mouse Zfp36 locus, the targeted features
in the mutant locus, and after the Cre-mediated deletion of Zfp36 WT exon 2 and the PGK-Neo selection cassette. The arrows indicate the sizes
of the NsiI- or PvuII-digested fragments from normal Zfp36 or from the correctly targeted mutant locus. Ns, NsiI; Pv, PvuII; E1, exon 1; E2, exon
2; SA, splice acceptor; loxP, speciﬁc binding sites for Cre DNA recombinase; FRT, ﬂippase recognition site; pA, BGH-poly(A) (in light blue). Exons
from WT Zfp36 are colored dark blue, the mutated exon 2 (with a single T-to-C substitution) is in red, and the PGK-Neo selection cassette is in
green. (B) Mouse TTP TZF domain peptide sequence, with the arrow pointing at position 116 in the intact protein, where the cysteine in the WT
protein has been changed to an arginine in the mutant protein (C116R) by the single T-to-C substitution in Zfp36. (C) Image of a PCR genotyping
gel. Lane 1 shows the DNA ladder, lane 2 used water instead of a DNA template, the single 546-bp band in lane 3 demonstrates that the normal
exon 2 of Zfp36 has been deleted from both alleles, the single 446-bp band in lane 4 indicates a normal Zfp36 locus in both alleles, and the double
band in lane 5 shows that the normal exon 2 of Zfp36 has been deleted from one allele (upper band) and the other allele remains WT (lower band).
(D) Sample gel shift using a TNF mRNA-based ARE probe. In lane 1, probe alone was run on the gel; in lane 2, an extract from cells transfected
with vector (BS) was used (note the various bands that were formed from the binding of endogenous 293 cell proteins to the probe); in lanes
3 and 4, extracts were used from cells transfected with either WT human TTP (hTTP) (lane 3) or its point mutant (lane 4); in lanes 5 and 6, extracts
were used from cells transfected with either WT mouse TTP (mTTP) (lane 5) or its corresponding point mutant (lane 6). The migrations of the major
TTP-probe complexes (TTP), a readily visible endogenous 293 cell protein-probe complex (line), and the unbound free probe (FP) are indicated
to the right of the autoradiograph. (E) Sample Western blot of 293 cell extracts. The lane numbers in panels D and E correspond to the same
extracts used for the gel shift and the Western blot.
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Phenotype of the C116R KI mice. (i) Body weight. The characteristic pattern of
body weight gain of WT C57BL/6 mice in our colony is illustrated in Fig. 2 (left panels,
males [M]; right panels, females [F]). When homozygous KI mice (Fig. 2A, red) were
compared to homozygous KO mice (Fig. 2B, red), there were no statistically signiﬁcant
differences between growth curves for either sex. This simple measurement is a
powerful index of the “TTP deﬁciency phenotype” in mice. This result suggests that the
KI protein, despite its apparently normal regulated expression (see below), was com-
pletely ineffective at preventing the development of the KO phenotype of slow weight
gain. In turn, this suggests that the actions of intact TTP to prevent development of this
aspect of the TTP deﬁciency syndrome could be completely blocked by the single
mutation that prevented binding to its target mRNAs.
The other important observation in this experiment concerned the comparison of
the growth curves between the heterozygous KI animals and the heterozygous KO
animals. Both the heterozygous KO and KI male mice had slightly but not signiﬁcantly
lower body weights than their WT controls at most ages (Fig. 2, left panels). Similarly,
there were no signiﬁcant differences between the two types of female heterozygotes
and their WT counterparts (Fig. 2, right panels). These data indicate that there was no
further deleterious effect of the KI mutation over and above its loss of function. This
provides strong evidence that the mutant protein does not exert a “dominant-negative
effect” on this aspect of the phenotype.
(ii) Other aspects of the phenotype. In general, the other aspects of the KI
phenotype closely matched those of the original KO phenotype on this genetic
FIG 2 Growth curves of C116R KI and total TTP KO mice. Body weights were measured weekly from 4 to 32 weeks of age. The results are expressed
as mean  SD. In general, 3 to 9 mice were used in each group, although fewer mice were available in the TTP KO or C116R KI groups at older
ages. (A) Average weights of homozygous C116R KI mutant mice and their corresponding WT and heterozygous (Het) counterparts; data from
male mice are shown in the left panel, and data from female mice are shown in the right panel. (B) Average weights of homozygous TTP KO mice
and their corresponding WT and Het counterparts, with males on the left and females on the right. There were no signiﬁcant differences between
the body weights of homozygous KI mice and homozygous KO mice, as determined by cubic polynomial growth curve analysis. Similarly, there
were no differences between the growth curves of any of the heterozygous mice and those of their WT counterparts.
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background. Speciﬁcally, the mice developed severe polyarthritis, particularly of joints
of the paws, along with accumulation of neutrophils in the soft tissues of the paws;
their body fat was severely depleted in comparison to that of their control littermates;
and there was evidence of severe myeloid hyperplasia, both within the bone marrow
and at extramedullary sites (data not shown). They also exhibited signiﬁcant increases
in circulating neutrophils (Table 1) (2-fold in males and 4-fold in females) and
monocytes (Table 1) (2-fold in males and 4-fold in females).
(iii) Bone mineral density and erosions in the C116R mutant mice. The effects of
TTP deﬁciency on bone metabolism were not studied in any detail in our original
description of the TTP deﬁciency syndrome (11). To evaluate the possibility of bone loss
in the KI mice, we evaluated bone mineral density in four groups of mice (n 5 in each)
at approximately 12 weeks of age (Table 2). In comparison with WT male mice, KI male
mice exhibited a decrease in average bone mineral density of 18% (P 0.0062). For the
females, KI mice exhibited an average bone mineral density decrease of 24% (P 
0.0087).
All C116R KI mice, both male and female, exhibited red and swollen paws, starting
as early as 4 weeks of age. Bone destruction in the paws was examined by both
conventional radiography and micro-computed tomography (micro-CT). As shown in
the upper panels (KI) of Fig. 3, the front paws of both 3-month-old C116R KI female (Fig.
3A) and male (Fig. 3B) mice exhibited soft-tissue swelling and bone changes compared
to their WT counterparts (Fig. 3A and B, lower panels [WT]). The bone changes seen in
the radiographs include severe erosions and osteopenia (Fig. 3A and B, upper panels).
Evaluation by micro-CT showed that the KI mouse paws had severe bone erosions (Fig.
3C and D, upper panels) compared to paws from WT mice of the same age (Fig. 3C and
D, lower panels). The pathological changes were more severe at older ages (compare
4-month-old male [Fig. 3C, upper panel] 6-month-old male [Fig. 3D, upper panel]).
The same paws shown in Fig. 3D were used for hematoxylin-and-eosin (H&E)
staining and tartrate-resistant acid phosphatase (TRAP) staining (Fig. 4). In the KI paw,
there was evidence of severe myeloid hyperplasia (H&E, arrowheads) and inﬂamed
synovium with leukocyte inﬁltration (H&E, arrows). There was also widespread TRAP
staining (TRAP, arrows), indicating increased numbers of osteoclasts, compared to that
in the WT paw, where there was minimal detectable TRAP staining.
Taken together, these data demonstrate that the C116R mutant form of TTP, when
expressed from its normal locus in intact mice and under normal physiological regu-
lation, does not exert any obvious effects to modify the TTP deﬁciency phenotype in
TABLE 1 Absolute neutrophil, lymphocyte, and monocyte counts and their percentages of white cell counts in peripheral blood
Cell type
Male mice Female mice
Absolute count, 1,000/l (% of WBC)a
Pb
Absolute count, 1,000/l (% of WBC)
PC116R KI WT C116R KI WT
Neutrophils 1.96 0.92 (27 10) 0.69 0.32 (10 3) 0.003 (0.0005) 2.46 1.30 (33 11) 0.62 0.23 (12 3) 0.003 (0.0004)
Lymphocytes 4.81 1.74 (66 10) 5.34 1.05 (85 3) NS (0.0003) 4.59 1.77 (61 12) 4.51 1.14 (84 3) NS (0.0004)
Monocytes 0.22 0.12 (2.89 1.62) 0.12 0.05 (1.67 1.00) 0.03 (NS) 0.28 0.15 (3.44 1.01) 0.06 0.04 (1.22 0.67) 0.002 (0.0001)
WBC 7.22 2.33 6.32 1.29 NS 7.50 2.31 5.42 1.38 0.03
aResults are expressed as average  SD. Nine mice at of each group (C116R KI or WT) were used 12  1 weeks of age.
bP values were determined using unpaired, two-tailed t tests with Welch’s correction. NS, not signiﬁcant.
TABLE 2 Bone mineral density
Micea (sex) BMD, g/cm2 (avg  SD)b P value, KI vs WTc 95% conﬁdence interval
C116R KI (male) 0.042 0.004 0.0062 0.0039–0.015
WT (male) 0.051 0.002
C116R KI (female) 0.041 0.007 0.0087 0.0049–0.022
WT (female) 0.054 0.004
aFive 12-week-old mice were used in each group.
bThe bone mineral density (BMD) is the bone mineral content per area of bone being measured.
cP values were determined using unpaired, two-tailed t tests with Welch’s correction.
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the mouse. This suggests in turn that the important physiological effects of TTP on
mRNA stability, and its ability to function as an anti-inﬂammatory or “arthritis suppres-
sor” protein, all derive from its ability to bind RNA. It is premature to conclude that TTP
has no functions that cannot be attributed to its initial RNA binding, but this possibility
is suggested by these results.
Responses of TTP C116R macrophages. (i) Expression of the TTP C116R mRNA
and protein. With the KI approach, the manipulated gene should exhibit normal
patterns of mRNA and protein expression. To test this, we evaluated bone marrow-
derived macrophages (BMDM) from WT and KI mice for TTP mRNA and protein
expression after LPS stimulation (Fig. 5). At the mRNA level, TTP transcripts were barely
detectable at time zero in the cells of both genotypes (Fig. 5A, lanes 1 and 9), but mRNA
accumulated rapidly within 15 to 30 min of LPS stimulation, reaching a peak at about
60 min (Fig. 5A, lanes 4 and 12), and then fell back to lower levels at subsequent time
points. Although the initial LPS-induced expression was remarkably similar for the WT
and KI cells, quantitation of the mRNA levels by Northern blotting from ﬁve similar
experiments suggested that there was a modest increase in transcript levels in the KI
cells at later time points after stimulation (Fig. 5B), when the TTP mRNA levels at each
LPS treatment period were expressed as fractions of KI peak level.
At the protein level, there was minimal detectable protein at time zero in cells of
both genotypes (Fig. 5C, lanes 1 and 6), but in both cases there was a rapid increase in
immunoreactive protein that began at 30 min (not shown) and continued for 1, 3, and
6 h after LPS stimulation (Fig. 5C, lanes 2 to 4 and 7 to 9). There appeared to be a
modest increase in TTP protein in the KI cells relative to the WT cells from 1 to 6 h and
FIG 3 Paw imaging. The upper panels show the images from C116 KI mouse paws, and the lower panels show images from
the WT littermates. (A and B) Mouse paw X-rays from females (A) and males (B), both at 3 months of age. (C and D) Micro-CT
images of paws from 4- and 6-month-old male mice, respectively.
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a more pronounced accumulation at 24 h after LPS incubation (Fig. 5C, compare lanes
5 and 10). This apparent increase in the mutant TTP protein expression may be due to
the increased accumulation of the C116R mRNA in the KI cells, particularly at longer
periods of LPS incubation (Fig. 5B). The characteristic SDS gel migration variants seen
in this ﬁgure have been attributed to multiply phosphorylated forms of the protein (see
references 21 and 22 for reviews); these appeared to be roughly similar in the WT and
KI cells.
(ii) TNF mRNA accumulation and decay in TTP C116R macrophages. The best-
known mRNA target of TTP is the TNF transcript, which contains numerous potential
TTP binding sites within an AU-rich element in its 3=UTR, approximately 300 bases 5= of
the poly(A) tail in human and mouse. In macrophages derived from the original TTP KO
mice, there was a characteristic slowing of TNF mRNA decay when tested 4 h after LPS
stimulation of TTP KO macrophages, with increases in half-life of 2- to 3-fold (12). We
therefore tested BMDM from WT and TTP C116R KI mice and compared their patterns
of TNF mRNA accumulation after LPS stimulation (Fig. 5D and E) and their rates of
mRNA decay after treatment with actinomycin D (see below). As expected, there were
apparent increases in TNF mRNA levels at most time points after LPS stimulation of
both the WT and KI cells (Fig. 5D). Northern blotting data from ﬁve similar experiments
were quantitated by PhosphorImager analysis, and the TNF mRNA levels at each time
after LPS treatment are shown in Fig. 5E, expressed as fractions of the peak level in the
KI cells. There were greater accumulations of the TNF mRNA in the KI BMDM at all
time points after LPS stimulation between approximately 1 and 8 h; they returned to




FIG 4 Paw histology. The paws shown in Fig. 3D were used for histochemical staining. The upper panels
show staining from the C116 KI paw sections, and the lower panels show staining from the WT. The left
panels show sections stained with H&E, whereas the right panels show sections stained for TRAP. In the
H&E staining of the KI paw, the arrowheads indicate myeloid hyperplasia, and the arrows indicate
synovial tissues with leukocyte inﬁltration. In the TRAP staining of the KI paw, the arrows point to
osteoclasts, identiﬁed by their high expression of TRAP.
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nied by greatly increased amounts of TNF protein released from the KI cells into the
culture supernatants (Fig. 5F).
In WT cells, TNF mRNA levels exhibit a characteristic time course after LPS stimula-
tion, with a ﬁrst peak seen approximately 1 h after stimulation, followed by a brief
decline and then continued accumulation to higher levels (Fig. 5E). Because TTP protein
at later LPS incubation times could be modiﬁed by multisite phosphorylation and other
posttranslational events, it has been suggested that TTP is only transiently effective at
promoting TNF mRNA decay after LPS induction (21). We therefore investigated the
possibility that there would be different TNF mRNA decay patterns after different times
of LPS stimulation. To do this, we assayed the decay of TNF mRNA in BMDM after LPS
treatment of 1, 3, and 6 h. At these time points, the cells were treated with actinomycin
D to stop further transcription, and then they were harvested at various times for the
next 2 h. Northern blots from typical experiments of this type are shown in Fig. 6A and
C. When cells were treated for only 1 h with LPS, followed by actinomycin D, there was
marked stabilization of the TNF transcript in the TTP C116R KI cells (Fig. 6A). Data from
ﬁve similar experiments (each with a different pair of WT and KI cells) are quantitated
in Fig. 6B. The time for the TNF mRNA to decay to 50% of its original level (t50) increased
from 18  3 min (mean  standard deviation [SD]) in the WT cells to 69  15 min in
the C116R KI cells (P  0.0012) under these conditions. These results are essentially
identical to the effect of the TTP null mutation on macrophages (WT, 17  3 min; TTP
KO, 59  15 min [n  5, mean  SD, P  0.0027]) from a parallel study (not shown).
When the cells were stimulated with LPS for either 3 h or 6 h, the stabilization of the
TNF mRNA was still readily apparent in the KI cells (Fig. 6C, lanes 2 to 8) compared to
FIG 5 TTP and TNF mRNA and protein expression in BMDM after LPS stimulation. In all panels, BMDM were incubated with LPS for the
times indicated. (A) Northern blot of a typical LPS treatment experiment after hybridizing to a TTP probe. Each lane was loaded with 8 g
total RNA from C116R KI (lanes 1 to 8) or WT (lanes 9 to 16) cells. (B) Relative accumulation of TTP mRNA after LPS stimulation, expressed
as fractions of the peak response of the C116R KI cells (mean  SD) from ﬁve independent experiments identical to that shown in panel
A. (C) Western blot demonstrating TTP protein expression in BMDM in response to LPS. Lanes 1 to 5 contain protein extracts from C116R
KI cells, and lanes 6 to 10 are from WT cells. The upper panel shows the results of immunoblotting with an anti-mouse TTP serum, and
the lower panel shows the results of blotting with an antiactin antibody (Act), as indicated to the right of the blot. (D) Northern blot of
an RNA sample from the experiments shown in panel A, but this time hybridized to a TNF probe. (E) Relative accumulation of TNF mRNA
after LPS stimulation in the cells of the two genotypes, expressed as fractions of the peak response of the C116R KI cells (mean  SD)
from ﬁve independent experiments identical to that shown in panel D. (F) Mean values (from two independent experiments) of TNF
protein released from the BMDM into the culture medium after LPS treatment for the times indicated, as measured by ELISA; the data were
normalized by the amount of total RNA harvested from the cells after the LPS incubations.
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the WT cells (Fig. 6C, lanes 10 to 16). In cells treated with LPS for 3 h followed by
actinomycin D, the TNF mRNA decay t50 from ﬁve similar experiments (each using a
different pair of WT and KI cells) in WT cells was 38  12 min (mean  SD), and it
increased in KI cells to 124  13 min (P  0.0001) (Fig. 6D). In cells treated with LPS for
6 h (Fig. 6E), the TNF mRNA decay t50 from four similar experiments (each using a
different pair of WT and KI cells) increased from 33  14 min (mean  SD) in the WT
cells to 81  9 min in the C116R KI cells (P  0.0011). These results demonstrated that
the TNF mRNA was stabilized in the C116R KI cells even as long as 6 h after LPS
stimulation. Thus, TTP in the WT cells was still able to promote decay of the TNF mRNA
at 3 and 6 h after LPS stimulation, an observation similar to that found in the BMDM
from myeloid cell TTP-deleted mice (23).
(iii) Potential autoregulation of TTP mRNA turnover. The TTP mRNA 3=UTR
contains at least three potential TTP family member binding sites in a longer AU-rich
region (24), and it has long been proposed that TTP can regulate the stability of its own
mRNA (25, 26). We thought that using cells from the C116R KI mice would be an ideal
way to test this idea, since the KI mRNA differs from the WT transcript by only a single
FIG 6 TNF and TTP mRNA decay in BMDM after LPS stimulation. BMDM were pretreated with LPS for 1 h, 3 h, or 6 h and then incubated
with actinomycin D (Act D) for the times indicated. (A) A Northern blot hybridized to a TNF cDNA probe shows typical mRNA decay
patterns from cells of each genotype treated with LPS for 1 h, followed by Act D addition and subsequent sampling. (B) Decay curves of
TNF mRNA (mean  SD) from ﬁve independent experiments identical to that shown in panel A. (C) Typical examples of Northern blots
hybridized to a TNF cDNA probe after treatment of cells with LPS for 3 h (upper panel) or 6 h (lower panel), followed by the Act D
incubation time courses. (D and E) Decay curves of TNF mRNA after 3 h (D) and 6 h (E) of LPS pretreatment were calculated from multiple
experiments identical to those shown in panel C. Each shows means  SD from ﬁve (D) or four (E) independent experiments. (F) Northern
blot from a typical experiment with cells of both genotypes pretreated with LPS for 1 h, followed by an Act D incubation time course.
The blot was hybridized to a TTP cDNA probe. (G) Combined data from ﬁve independent experiments identical to that shown in panel
F (mean  SD). See the text for half-life determinations and other details.
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base, and the mutant allele is present in the native locus, where it is subjected to
normal regulation. The time course data on the LPS-stimulated expression of TTP mRNA
and protein shown above in Fig. 5 suggested that the mRNA levels were modestly
increased in the KI cells at many time points after stimulation (Fig. 5B) and that the
protein expression followed the same trend (Fig. 5C). We therefore compared TTP
mRNA decay proﬁles by Northern blotting after 1 h of LPS treatment of WT and KI
macrophages. As exempliﬁed by a typical experiment (Fig. 6F), there was modest
apparent stabilization of the TTP mRNA in the KI cells. When we averaged data from 5
identical experiments (Fig. 6G), the TTP mRNA decay t50 increased from 17  5 min
(mean SD) in the WT cells to 27 7 min in the KI cells (P 0.031). These data suggest
that TTP regulates the stability of its own mRNA but that the magnitude of this change
is relatively small.
(iv) NanoString analysis of other TTP target transcripts. We also performed
NanoString assays using RNAs from four mRNA decay experiments after various times
of LPS treatment to investigate several other potential target mRNAs that had been
identiﬁed by other experiments (Fig. 7). As internal controls for the efﬁcacy of the
actinomycin D treatment, we used the very labile Dusp and Socs3 mRNAs (Fig. 7A, top
panels). The levels of both control transcripts decreased rapidly to near 0% of the
original after actinomycin D treatment, and their decay patterns did not differ in the WT
and C116R cells (Fig. 7A). Cxcl1 and Cxcl2 mRNAs were obviously stabilized in the C116R
KI cells after 1 h of LPS treatment, but the differences between cells of the two
genotypes were less apparent after 3 h and disappeared altogether by 6 h (Fig. 7A). This
could largely be accounted for by the almost complete lack of measurable decay of the
two transcripts in cells of both genotypes after 6 h. The decay of Ier3 mRNA was
moderately slowed in the C116R KI cells at all time points, differences that were
signiﬁcant after 3 and 6 h of LPS pretreatment, whereas the decay of the IL-10 mRNA
was apparent at 1 h and 6 h but not after 3 h of LPS treatment (Fig. 7A). Cd274 mRNA
decayed very little under these conditions, even though there were signiﬁcant differ-
ences between the two genotypes after 1 or 3 h of LPS treatment. Ptgs2 mRNA was also
relatively stable, but the decay was signiﬁcantly different between the two cell types
after 3 h of LPS pretreatment (Fig. 7A).
As shown above and in Fig. 7B, the TTP mRNA levels in BMDM were relatively low
after the longer periods of LPS incubation. However, the slight effect of TTP on its own
mRNA decay seen after 1 h (Fig. 6F) could still be detected after 3 or 6 h of LPS
treatment followed by the addition of actinomycin D (Fig. 7A). The delay in TNF mRNA
decay in the mutant cells noted above in Fig. 6A to E was conﬁrmed by the NanoString
assays as occurring at all three time points after LPS stimulation (Fig. 7A).
The steady-state levels of these mRNAs in the basal state and after various times of
LPS stimulation are shown in Fig. 7B.
(v) Effect of cytokines and chemokines secreted by BMDM on ﬁbroblast tran-
scripts. As previously shown in TTP-deﬁcient BMDM (27–29), the C116R BMDM released
greater amounts of TNF protein than WT cells after stimulation by LPS (Fig. 5F). We
analyzed BMDM culture supernatants collected after 24 h of stimulation with LPS from
three different pairs of WT and C116R cells by multiplex analysis. In agreement with the
enzyme-linked immunosorbent assay (ELISA) results from typical experiments shown in
Fig. 5F, the amount of TNF protein released from the C116R cells was much greater than
that from the WT cells (Fig. 8A). Levels of other proinﬂammatory cytokines and
chemokines (IL-1, CXCL1, and CXCL2 [Fig. 8A] and CCL3 [Fig. 8B]) were also signiﬁ-
cantly increased in medium from the KI cells. Although average levels of IL-10 were
apparently increased in the supernatants from the KI cells (Fig. 8A), this increase was
not signiﬁcant. There were no differences in IL-6 or CCL5 levels (Fig. 8B) in the culture
supernatants from C116R KI and WT cells.
Given that BMDM from the C116R mice released more proinﬂammatory cytokines
after LPS stimulation than cells from WT mice and that ﬁbroblasts responding to
proinﬂammatory cytokines released from macrophages in turn produce chemokines
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FIG 7 NanoString analysis of BMDM mRNA decay. For NanoString analyses, we used total RNA samples from decay experiments represented by
the Northern blots in Fig. 6A and C, from C116R KI or WT BMDM pretreated with LPS for 1 h, 3 h, or 6 h, followed by actinomycin D time courses.
(A) Data are shown as fractions of the original mRNA remaining (mean  SD; n  4) during the Act D time course, with a value of 1.0 set for the
samples taken before Act D was added. The numbers in parentheses following the name of the mRNA indicate the numbers of core TTP binding
sites (UAUUUAU) found in the mRNA 3=UTR. The P values beneath the mRNA names indicate the variation in responses between the two
genotypes; see Materials and Methods for their determination. GenBank accession numbers for the transcripts are listed in Materials and Methods.
(B) Data are shown for mRNA levels (normalized counts) in KI or WT cells under control conditions (C) or after incubation in LPS for the times
indicated.
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that promote leukocyte recruitment (see references 30 and 31 for review), we investi-
gated whether supernatants from these BMDM could induce heightened chemokine
responses in WT and C116R mouse embryo ﬁbroblasts (MEFs). After a 30-min incuba-
tion with culture medium from 24-h LPS-stimulated BMDM, medium from the C116R KI
cells stimulated increased accumulations of Cxcl1 and Cxcl2 mRNAs in both WT and
C116R KI MEFs (Fig. 8C). Ier3 and TTP mRNAs were less obviously affected (Fig. 8C).
Responses of TTP C116R MEFs. We next tested whether the responses of TTP
C116R primary ﬁbroblasts were similar to those seen previously in complete TTP KO
ﬁbroblasts (29, 32). To do this, we exposed these cells to two proinﬂammatory stimuli,
TNF and interleukin-1 (IL-1), and to fetal bovine serum (FBS), a potent stimulator of
TTP induction in ﬁbroblasts (16, 32) (Fig. 9A). FBS induced the expression of Ier3 and
TTP mRNAs in both C116R KI and WT mouse embryo ﬁbroblasts (MEFs) (Fig. 9A, lanes
2 and 6) but had a minimal effect on the expression of Cxcxl1 or Cxcl2 mRNA.
FIG 8 Cytokines and chemokines released into BMDM culture supernatants. (A and B) Levels of cytokines and chemokines released into the
incubation medium (1% FBS in RPMI) of BMDM from WT or C116R KI mice after incubation for 24 h either without (0) or with (24) LPS added to
the medium. The data are from three independent experiments that each consisted of a different pair of C116R KI and WT mice (mean  SD)
The numbers above the C116R KI bars indicate the P values from comparing the results of the KI and WT cells after 24 h of LPS incubation using
unpaired two-tailed t tests with Welch’s correction (NS, not signiﬁcant). These culture supernatants were then used to treat MEFs isolated from
WT and C116R embryos. (C) Representative Northern blots of RNA isolated from MEFs that were hybridized to Cxcl1, Cxcl2, Ier3, or TTP cDNA
probes. The migration positions of the mRNAs are indicated to the right of the blots, and the migration position of the 18S RNA is indicated to
the left. Lanes 1 to 6 were loaded with RNA from C116R KI cells, and lanes 7 to 12 contained RNA from WT cells. MEFs either remained in the
serum starvation medium (lanes 1 and 7) or were changed to BMDM culture supernatants from C116R KI or WT cells (BMDM sup). These were
collected from BMDM under conditions without LPS (0; lanes 2, 4, 8, and 10) or after LPS treatment for 24 h (24; lanes 3, 5, 9, and 11) or were
changed to fresh 1% FBS in RPMI (FBS, lanes 6 and 12). Cells were harvested for RNA puriﬁcation after 30 min of further incubation. Three similar
experiments, each using a different pair of C116R and WT MEFs, were performed, and the results were similar to those shown in panel C.
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TNF has been shown to be a major contributor to the systemic TTP deﬁciency
syndrome (11, 27), and it is a key effector of leukocyte inﬁltration into speciﬁc tissues
(28, 29, 33). In a previous study comparing TTP KO MEFs with their WT counterparts, we
showed that TTP regulated the decay of several mRNAs encoding TNF-induced cyto-
kines and chemokines (29). In the current study, TNF induced the expression of Cxcl1,
Cxcl2, Ier3, and TTP mRNAs in both WT and C116R cells (Fig. 9A, lanes 3 and 7), with
peaks of accumulation at approximately 30 min after TNF addition (not shown). We
therefore performed actinomycin D time courses after 30 min of TNF stimulation. Cxcl1,
Cxcl2, Ier3, and TTP mRNAs were all modestly stabilized in the C116R cells relative to WT
cells (Fig. 9B, compare lanes 3 to 7 to lanes 10 to 14), all with decay proﬁles similar to
those seen when the TTP KO and WT MEFs were compared (29).
Interleukin 1 (IL-1) is another cytokine involved in local tissue leukocyte inﬁltra-
tion and inﬂammation (for reviews, see references 34 and 35). Exposure of the MEFs to
IL-1 also caused increases in the expression of Cxcl1, Cxcl2, Ier3, and TTP mRNAs (Fig.
9A, lanes 4 and 8). After IL-1 stimulation, both Cxcl1 and Cxcl2 mRNA levels peaked
FIG 9 mRNA decay in MEF. MEFs were serum starved overnight before the indicated treatments. Each type of experiment shown is representative
of three similar experiments, each using a different pair of C116R KI and WT MEF. (A) MEFs of the indicated genotype were either left untreated
(lanes 1 and 5) or treated with 10% FBS (lanes 2 and 6), 10 ng/ml TNF (lanes 3 and 7), or 10 ng/ml IL-1 (lanes 4 and 8) for 30 min, as shown. Total
cellular RNA from those treatments was used to prepare Northern blots, which were hybridized to Cxcl1, Cxcl2, Ier3, and TTP cDNA probes. The
migration positions of the mRNAs are indicated; lines point to smaller species in the Cxcl1 and Cxcl2 hybridizations. (B and C) MEFs were
pretreated with either TNF (10 ng/ml) (B) or IL-1 (10 ng/ml) (C) for 30 min and then incubated with Act D for the times indicated. Northern blots
were hybridized to Cxcl1, Cxcl2, Ier3, or TTP cDNA probes. Representative Northern blots are shown (D) Decay curves after Act D incubation from
three independent experiments identical to that shown in panel C (mean  SD). In panels B and C, the migration positions of the mRNAs are
indicated, with the upper arrow pointing to the fully polyadenylated mRNA and the lower arrow pointing to the deadenylated mRNA species.
In the upper two panels of panels A and B, smaller degradation products were seen for Cxcl1 and Cxcl2 mRNAs after TNF treatment, but these
were not seen after IL-1 stimulation (A and C). See the text for half-life determinations and other details.
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at 45 min, whereas Ier3 and TTP mRNAs peaked at 30 min (not shown). TTP protein
expression in MEFs was readily detectable after 30 min of incubation with FBS, TNF, and
IL-1 (not shown). There was a modest increase in TTP protein expression in the KI cells
compared to WT cells after TNF and FBS stimulation, although this increase in the KI
MEFs was not seen after IL-1 stimulation (not shown).
To compare the stabilities of Cxcl1, Cxcl2, Ier3, and TTP mRNAs in the C116R and WT
MEFs in response to IL-1, we ﬁrst treated the cells with IL-1 for 30 min, followed by
an actinomycin D time course. In each of the three experiments performed, we used
MEFs prepared from pairs of littermate embryos from separate litters. As illustrated in
the typical Northern blots shown in Fig. 9C, the mRNAs for Cxcl1, Cxcl2, and Ier3
remained relatively stable in the C116R cells, whereas in the WT cells they decayed
much more rapidly (Fig. 9C, lanes 2 to 7 compared to 9 to 14). In addition, in the WT
cells, the Cxcl1, Cxcl2, and Ier3 mRNAs exhibited the rapid generation of lower-
molecular-weight mRNA intermediates, which ﬁrst became apparent after 20 min of
incubation with actinomycin D (Fig. 9C, lanes 11 to 14). This presumably reﬂects the
accumulation of smaller deadenylated intermediates, a pattern that has been observed
previously in the TTP-regulated decay of GM-CSF mRNA (36). In the present experi-
ments, the effect of the C116R mutation was not only to stabilize the Cxcl1, Cxcl2, and
Ier3 mRNAs but also to inhibit the formation of the deadenylated intermediates (Fig. 9C,
compare lanes 4 to 7 to lanes 11 to 14). When data from the three experiments were
quantitated (Fig. 9D), there was signiﬁcant stabilization of Cxcl1, Cxcl2, and Ier3 mRNAs
in the C116R cells. The calculated t50s for these transcripts (mean SD) were as follows:
Cxcl1, 26 7 min in the WT MEFs versus 128 11 min in the C116R MEFs (P 0.0092);
Cxcl2, 27  5 min in the WT MEFs versus 161  22 min in the C116R MEFs (P  0.024);
and Ier3, 16  6 min in the WT cells versus 35  4 min in the C116R cells (P  0.009).
In these experiments, there was only a minor difference in the decay of TTP mRNA, with
a t50 of 12  6 min in the WT cells versus 20  4 min in the C116R cells (P  0.113).
DISCUSSION
Previous RNA gel shift studies in cell extracts have shown that mutation of any of the
eight zinc-coordinating residues within the TTP TZF domain can prevent high-afﬁnity
RNA binding (20; W. S. Lai and P. J. Blackshear, unpublished data). Similarly, cell
transfection assays with the same mutants have shown that the mutant TTP is inactive
in promoting target mRNA deadenylation and accelerating its decay (20, 37). These
data suggest that all of TTP’s physiological roles might require initial high-afﬁnity
binding to AU-rich element sites within the 3=UTRs of target transcripts. Answers to this
question should be relevant to other members of the greater TTP protein family,
deﬁned by the presence of the canonical TZF domain, which are widely distributed
among eukaryotes from plants to humans (38, 39).
This idea has been tested in the ﬁssion yeast, Schizosaccharomyces pombe, in which
two different, analogous point mutations were made in the TZF domain of the single
TTP family member expressed in that species, Zfs1. Based on the ﬂocculation pheno-
type seen with Zfs1 deﬁciency, as well as a “molecular phenotype” of characteristic
patterns of target transcript accumulation in the Zfs1-deﬁcient strains, we concluded
that knocking in TZF domain point mutations into the endogenous zfs1 locus could
phenocopy the complete deletion mutant (40). However, to our knowledge, the
analogous mutation in an endogenous locus has not been attempted in a metazoan
organism.
In the present studies, we made a single-base mutation in the endogenous mouse
Zfp36 locus, encoding TTP, that resulted in a C-to-R mutation at C-116 in the expressed
protein (GenBank accession no. NP_035886.1). We demonstrated essentially normal
regulation of the mutant TTP mRNA and protein in response to stimuli in cultured cells
from WT and littermate homozygous TTP KI mice, with perhaps slightly more stable
C116R mRNA and a moderate to more pronounced increase in the mutant TTP protein
accumulation after longer stimulation with LPS. Based on several aspects of the
phenotype, we could not distinguish the phenotype of these mutant mice from that of
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the original TTP KO mice, suggesting that most if not all of TTP’s roles in normal
physiology stem from its initial ability to bind to AU-rich targets with high afﬁnity. By
extension, this general concept could apply to the family members found throughout
eukaryotes.
However, there are several examples in the literature of other possible TTP effects,
for example, effects on gene transcription (41–43). This is plausible because of TTP’s
nucleocytoplasmic shuttling ability (44) and suggests that its periodic nuclear localiza-
tion may be relevant to this proposed transcriptional activity. TTP family members in
other species have also been proposed to have transcriptional activity, such as the two
proteins of this type expressed in Arabidopsis thaliana (45, 46). However, we have found
in previous cell-free binding experiments that TTP did not bind with appreciable afﬁnity
to sequences analogous to its RNA binding sites in single- or double-stranded DNA (Lai
and Blackshear, unpublished data). Nonetheless, TTP could be interacting through its
TZF domain with other DNA sequences and could be acting as a coactivator or
corepressor of transcription in the absence of direct DNA binding (41, 42). Interactions
of TTP with other proteins also could persist despite the zinc ﬁnger mutation. Some of
these interactions are known to be modiﬁed by phosphorylation (22, 47, 48), and we
expect that most TTP phosphorylations would occur normally in the mutant protein.
TTP is known to interact directly with other mRNA-interacting proteins or protein
complexes, such as cytoplasmic poly(A) binding protein, AUF1, and the CCR4-NOT
complex (49–52), all of which could occur without the need of interaction between
TTP’s TZF domain and its target mRNA binding sites. However, as best we can tell from
our phenotyping analyses, the phenotype of the zinc ﬁnger mutant KI mice is very
similar if not indistinguishable from that of the KO mice. Nonetheless, our current
experiments do not entirely exclude physiological roles for TTP that are independent of
RNA binding.
We also wished to use these mice, and cells derived from them, to address several
other long-standing issues relating to mammalian TTP physiology. In one case, previous
studies showed that at low concentrations of transfected DNA, coexpression of target
mRNAs with TTP containing a single point mutation of a zinc-coordinating residue
within the TZF domain completely failed to promote mRNA deadenylation and decay
(16). However, at higher levels of expression, these mutant proteins actually inhibited
the deadenylation and decay of cotransfected TTP target transcripts (20). A possible
explanation was that the mutant protein was interfering with protein binding partners
that were involved in deadenylation and decay. It raised the question of whether an
analogous allele expressed in a heterozygous live animal might exert a “dominant-
negative” effect on the normal protein expressed from the WT allele. The experiments
presented here show no support whatsoever for this possibility, which should have
been revealed by the comparisons between the Zfp36WT/KO heterozygotes and the
Zfp36WT/KI heterozygotes.
Another question concerns the effects of TTP to regulate the stability of its own mRNA.
As shown in this paper and elsewhere, TTP mRNA has a remarkably short half-life in
macrophages and ﬁbroblasts after LPS and TNF stimulation, of approximately 17 and 12
min, respectively, in WT cells. In genome-wide studies of both stimulated and normally
growing cells, it regularly appears within the group of mRNAs with the shortest half-lives in
various types of cells. It also contains several optimal and conserved TTP binding sites
within its 3=UTR, contained within a longer stretch of AU richness that has been shown to
confer instability on this mRNA (53). It was certainly plausible that TTP should regulate the
stability of its own mRNA, and this concept has been supported by previous cell transfec-
tion experiments (25, 26). However, we viewed the current mouse model, in which only a
single base has been altered in the endogenous mRNA, as the best possible model to test
this idea in various cell types.
The results of these experiments seem clear. When actinomycin D was added to
macrophages analyzed 1 h after LPS stimulation, when TTP transcript levels are near
their peak, and transcript decay was monitored, there was a consistent and statistically
signiﬁcant slowing of TTP mRNA decay. In this situation, as determined by Northern
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blotting of RNA from ﬁve littermate mice in each group, the half-lives of the transcripts
increased from 17 min in the WT cells to 27 min in the KI cells. In ﬁbroblasts, there was
a similar minor degree of slowing of mRNA decay in the mutant cells. The transcripts
could well behave differently in different cell types or in response to different stimuli,
but in this case the clear result seems to be that TTP mRNA is slightly but signiﬁcantly
stabilized in the absence of the functional TTP protein.
Several other aspects of this mouse model deserve mention. In the present exper-
iments, both the heterozygous Zfp36WT/KO and Zfp36WT/KI mice exhibited slightly
(although not signiﬁcantly) lower body weight than their WT counterparts, suggesting
that a single functional allele, even under normal physiological regulation, is not quite
sufﬁcient to maintain completely normal patterns of weight gain. Larger numbers of
mice in each group would be required to document this proposed “haploinsufﬁciency.”
At the molecular level, we have found no differences in TNF mRNA decay patterns in
BMDM derived from WT or Zfp36WT/KI mice (not shown). Both groups of heterozygous
mice were otherwise generally healthy, although occasional mice have developed what
appears to be typical “TTP deﬁciency syndrome” late in life. It will be interesting to
dissect this possible TTP inadequacy by doing, for example, stimulation experiments
with LPS or infectious diseases in intact mice.
Another interesting aspect of this study concerns the severity of the bone pheno-
type in the homozygous KI mice. In the original description of the phenotype of the KO
mice, we described destruction of bone around the sites of the inﬂammatory arthritis.
However, the X-ray, micro-CT, and bone mineral density results presented here suggest
that there is widespread general as well as focal bone loss, not only in the joints but in
the long bones of the digits and elsewhere. Within the bones of the paws, there were
clear increases in stainable osteoclasts, suggesting that both the local erosions and
bone loss, and perhaps the systemic osteopenia, were the result of increased osteoclast
activity. The mechanisms of these effects on bone are not clear, although the proin-
ﬂammatory cytokines TNF, IL-1, and IL-6 are all known to affect osteoclastogenesis (for
reviews, see references 35, 54, and 55). In addition, we have found that both TNF and
IL-1 induced higher levels of release of the CCL3 chemokine from the C116R KI
macrophages than from WT cells (not shown). Previous studies have shown that the
severity of synovial inﬁltration and bone erosion in the TTP KO mice could be reduced
when Ccl3 was also deleted (56), though the deletion of Ccl3 did not appear to prevent
other signs of inﬂammation in the TTP KO mice.
Finally, there has been some discussion in the literature that TTP is mainly or only
active shortly upon its induction and that the widespread phosphorylation of the
protein that occurs after translation inhibits its activity, perhaps by the sequestering of
phosphorylated TTP by 14-3-3 proteins (for a review, see reference 22). In the current
study, we evaluated the effects of the TTP mutant on target transcript stability at 1, 3,
and 6 h after LPS stimulation of macrophages. Although there were differences in the
effects of TTP deﬁciency on decay rates at different times among the different target
transcripts, some of the targets, for example, the TNF mRNA, were clearly stabilized in
the absence of functional TTP at 1, 3, and 6 h after LPS stimulation. Other differences,
such as the loss of effect on Cxcl1 and Cxcl2 mRNAs after 3 h of stimulation, can
probably be attributed to the nature of the mRNA time courses of these transcripts after
stimulation of the cells. It seems clear from these data that TTP is active enough to
promote mRNA decay at 1, 3, and 6 h after LPS stimulation in macrophages. Whether
it is optimally active at these later time points cannot be determined by the present
experiments.
In summary, we have developed a new point mutant model of effective TTP
deﬁciency that has been used to answer several long-standing questions about TTP
biology in the intact animal. We believe that the lessons learned from this model should
be applicable to the physiological roles of the TTP family members found throughout
eukaryotes. As usual, these experiments leave many questions to be addressed by
future studies.
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Animal procedures, genotyping, and sequence analysis of the KI allele. Conditional knock-in (KI)
mice containing a point mutation in the ﬁrst zinc ﬁnger in the second exon of Zfp36 were generated by
Ozgene Pty Ltd. (Perth, Australia), using standard embryonic stem (ES) cell targeting techniques. The
third cysteine in the ﬁrst zinc ﬁnger was mutated to arginine by changing the ﬁrst nucleotide of the
codon from T to C (TGC mutated to CGC [T377C] in the sequence under GenBank accession no.
NM_011756.4). The targeting construct was generated from C57BL/6 genomic DNA and cloned into the
Ozgene PacF vector. The ﬁnal targeting vector contained a 5= homology arm with a loxP site before the
wild-type (WT) exon 2 encompassing the zinc ﬁngers and a bovine growth hormone poly(A), a
phosphoglucokinase (PGK)-neomycin (Neo) cassette ﬂanked by Flp recombinase recognition (Frt) sites,
and a loxP site followed by a 3= homology arm containing the mutated (T377C point mutation) exon 2.
All fragments in the targeting vector were generated by PCR and conﬁrmed by restriction enzyme
digestion and sequencing. C57BL/6 ES cells were electroporated with PmeI-linearized targeting vector.
Correctly targeted ES cells were identiﬁed by Southern analysis using a 5= probe with an NsiI digestion
and a 3= probe with a PvuII digestion (Fig. 1A). The sizes of the arrows in Fig. 1A indicate the sizes of the
NsiI- or PvuII-digested fragments from the normal Zfp36 locus or from the correctly targeted mutant
locus. Both probes lay outside the targeting vector. Random integrations were identiﬁed with a Neo
probe and XbaI, NsiI, or EcoRI digestion. An endogenous probe was used with EcoRV digestion to detect
either Cre-mediated or enhanced Flp (Flpe)-mediated deletion of the PGK-neomycin cassette. These mice
permit the conditional KI of the point mutation. The targeted mice were bred with an Flpe deleter mouse
to remove the PGK-neomycin cassette, resulting in mice containing a ﬂoxed wild-type exon 2 and a
mutant exon 2. A conditional KI of the mutant exon 2 could be achieved by breeding with a speciﬁc
Cre-expressing mouse. For our study, the targeted mice were bred with a Cre deleter mouse at Ozgene,
which removed both the wild-type exon 2 and the PGK-neomycin cassette, resulting in the KI of the
mutant exon 2.
Heterozygous KI mice were bred with Taconic C57BL/6N mice to remove the Cre transgene and then
intercrossed to generate homozygous KI mice for the exon 2 point mutation. Offspring were routinely
genotyped using a 5= primer, 5=-AGGTTCTCCCTGGAGTTTGTGTG-3=, and a 3= primer, 5=-GCTTTCTGAGTA
GGTCCGACAG-3=. These primers ampliﬁed a 446-bp endogenous Zfp36 WT allele and a 546-bp Cre-
mediated Zfp36 KI allele containing the point mutation in exon 2 (Fig. 1C). PCR conditions were as
follows: 93°C for 2 min and then 30 cycles of 93°C for 30 s, 58°C for 30 s, and 72°C for 1 min, with a ﬁnal
extension at 72°C for 10 min. Conﬁrmation of the point mutation in the KI mice was done by sequencing
a 539-bp fragment of exon 2 ampliﬁed using a 5= primer, 5=-GGGCCGAAGCTGTGGCTGGGT-3= and a 3=
primer, 5=-TTCGAGTCACAGGGGTCCCAG-3=.
All animal procedures were conducted according to U.S. Public Health Service policy on the humane
care and use of laboratory animals, and the National Institute of Environmental Health Sciences
Institutional Animal Care and Use Committee approved all animal procedures used in this study.
Body weights were measured weekly from 4 weeks after birth until 32 weeks of age. We compared
possible differences among the growth curves using cubic polynomial growth curve analysis (57, 58).
Histopathology and clinical pathology. Animals were euthanized between 6 and 16 weeks of age,
and tissues were ﬁxed in 10% neutral buffered formalin and used for parafﬁn embedding, sectioning
(5-m sections), and staining with hematoxylin and eosin. Peripheral blood was collected via retro-orbital
bleeding into EDTA-containing Microvette collection tubes (Sarstedt, Inc., Newton, NC) and analyzed
using a Hemavet 1700 hematology analyzer (Drew Scientiﬁc, Inc., Miami Lakes, FL). White blood cell
(WBC) differential counts were also performed manually to conﬁrm the values. For some mice, peripheral
blood was collected into Microvette collection tubes containing serum gel/clotting activator (Sarstedt,
Inc., Newton, NC). After clotting, the tubes were centrifuged for 5 min at 10,000 g at room temperature.
The resulting serum was stored at 	80°C until analyzed by ELISA.
Bone mineral density determination, X-rays, and micro-CT. Four groups (n  5 in each) of
12-week-old male and female mice, WT or C116R KI, were used for the measurement of bone mineral
density and for routine radiograms. Each mouse was anesthetized with 2% isoﬂurane in 700 ml O2/min
(induced in a chamber at 5% isoﬂurane and maintained by a face mask), and whole-body (head excluded)
bone mineral density was obtained using a PIXImus small-animal densitometer (Lunar, Madison, WI).
Bone mineral density (g/cm2) was expressed as bone mineral content/surface area of bone being
measured. The anesthetized mice were then subjected to X-ray imaging in an MX20 system (Faxitron,
Tucson, AZ).
Front paws from male WT and KI mice (age 4 and 6 months) were stabilized in 2% agarose gel and
analyzed by a micro-computed tomography system (CT 40; Scanco Medical AG, Zurich, Switzerland) to
obtain three-dimensional (3D) images (59, 60).
Histology and histomorphometry. For histology to detect osteoclasts and immune inﬁltrates, intact
front paws were ﬁxed in 10% (vol/vol) buffered formalin overnight and decalciﬁed by using 14% (wt/vol)
EDTA in double-distilled water (ddH2O) (pH 7.0) for 10 days, with gentle rocking and daily replacement
of the solution (60). Decalciﬁed bones were then dehydrated in graded alcohol, cleared through xylene,
and embedded in parafﬁn. Parafﬁn blocks were sectioned longitudinally. Five-micrometer sections were
then stained with TRAP (Sigma) to detect osteoclasts and counterstained with hematoxylin. Hematoxylin-
and-eosin staining was used to evaluate the extent of inﬂammation.
TTP protein expression and RNA mobility shift assays. Expression constructs CMV.hTTP.tag and
CMV.mTTP.tag and their zinc ﬁnger mutants for human (GenBank accession no. NP_003398.1) and mouse
(GenBank accession no. NP_035886.1) TTP have been described previously (16). These plasmids were
expressed in HEK293 cells using the calcium phosphate precipitation method as described previously (20,
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61). Brieﬂy, to each 10-cm plate of cells was added 0.2 g CMV.TTP.tag or mutant DNA and 4.8 g vector
(BS) DNA. Vector (BS) DNA (5 g) was added to each control plate. Cytosolic extracts were prepared
24 h after removal of the transfection mixture as described previously (37, 61). These were in ﬁnal
concentrations of 10 mM HEPES (pH 7.6), 40 mM KCl, 1 g/ml pepstatin A, 0.1 mM phenylmethylsulfonyl
ﬂuoride (PMSF), 1 g/ml leupeptin, and 20% glycerol and were stored at 	80°C. Gel shift assays were
performed using as a probe a [32P]pCp-3=-end-labeled synthetic RNA oligonucleotide, TARE5 (based on
the AU-rich element within the mouse TNF mRNA 3=UTR, GenBank accession no. NM_013693.2, bp 1301
to 1332) and the HEK293 cell extracts as described previously (61). Each probe-protein binding reaction
mixture of 0.2 nM TARE5 probe and 10 g extract protein was incubated at 20°C for 30 min in 10 mM
HEPES (pH 7.6), 3 mM MgCl2, 40 mM KCl, and 5% glycerol in a ﬁnal volume of 50 l. The RNA-protein
complexes formed were resolved on 8% nondenaturing acrylamide (37.5:1) gels.
Macrophage cultures. Bone marrow-derived macrophages (BMDM) were obtained by culturing
bone marrow cells from femurs in macrophage growth medium (RPMI 1640 medium with 10% FBS, 30%
L929 cell culture supernatant, 100 U/ml penicillin, 100 g/ml streptomycin, and 6 mM L-glutamine) in
10-cm tissue culture plates. Four or 5 days after initiating the cultures, the cells still in suspension were
collected and seeded onto new plates for use in experiments. The transferred cells were fed every other
day by adding 2 to 3 ml of fresh macrophage growth medium to each plate. After 7 to 10 days of culture
in macrophage growth medium, the 70 to 80% conﬂuent BMDM monolayers were incubated in RPMI
1640 medium (10 ml in each plate) supplemented with 1% FBS and the antibiotics for 16 to 24 h before
the experiments.
BMDM cell culture supernatants harvested for use as agonists in primary mouse embryonic ﬁbroblast
(MEF) experiments were prepared as follows. BMDM grown to 90% conﬂuence were incubated in 1%
FBS–RPMI overnight, followed by an additional 24 h of incubation with or without 1 g/ml LPS. The
culture supernatants were collected through a ﬁlter to remove any ﬂoating cells and stored at 	20°C.
Primary embryonic ﬁbroblast cultures. Primary embryonic ﬁbroblasts (MEFs) were prepared from
embryos at embryonic day 14.5 (E14.5) of gestation. Only the bodies (heads and internal organs
excluded) were used for the preparation. The genotypes of each embryo were determined using
genomic DNA from the embryo head and the pair of PCR primers describe above. MEFs were cultured
in 10-cm plates in Dulbecco modiﬁed Eagle medium (DMEM) with 10% FBS, 100 U/ml penicillin, 100
g/ml streptomycin, and 2 mM L-glutamine. Four pairs of MEF cultures from littermate mice (C116R KI
and WT), each pair from a different litter, were used in experiments at passages 3 to 8. When MEFs in
culture reached 80 to 90% conﬂuence, the cell monolayers were rinsed with DMEM and incubated in
serum starvation medium (DMEM with 0.5% FBS, 100 U/ml penicillin, and 100 g/ml streptomycin) for
16 to 24 h before the experiments.
Cell treatments, RNA preparation, and Northern blotting. For each time course experiment using
BMDM or MEFs, as indicated, 4 plates of cells from each genotype were set aside as controls (untreated),
and 3 plates of cells were used for each time point stimulation with the indicated reagent (LPS [Sigma
L6529], recombinant mouse TNF [R&D Systems], and recombinant mouse IL-1 [R&D Systems]). As stock
solutions, LPS was reconstituted in H2O to 1 g/l, and TNF and IL-1 were reconstituted to 10 ng/l in
phosphate-buffered saline (PBS) with 0.2% bovine serum albumin (BSA). At the end of each treatment
period, cell monolayers were quickly rinsed in cold PBS and lysed in lysis solution (Illustra RNAspin mini;
GE Healthcare). The lysates from the 3 plates from the same treatment time point (or 4 untreated plates)
were pooled, and cellular RNA was prepared according to the manufacturer’s protocol.
The mRNA decay assays were performed as follows. For each experiment, 4 plates of cells of each
genotype were used as controls (untreated), and 4 plates were used as pretreatment references (i.e., after
stimulation with LPS in the case of BMDM or with TNF or IL-1 in the case of MEFs). At the end of the
indicated pretreatment period, these reference plates were quickly rinsed with cold PBS, and the cells in
monolayers were lysed in lysis solution. Thereafter, three plates of cells were combined for use for each
mRNA decay point. Actinomycin D (Sigma, A4262; 5 g/ml) was added to these plates precisely at the
end of the indicated pretreatment period to stop RNA transcription, and the cells were further incubated
for the indicated times, followed by cold PBS rinses and cell lysis as described above.
For Northern blotting, each gel lane was loaded with 8 g of total RNA unless otherwise indicated.
Northern blotting was performed, and the -32P-labeled probes for mouse TNF, TTP, Ier3, and Cxcl1
mRNAs were prepared, as described previously (4, 9, 32). The probe for mouse Cxcl2 mRNA was prepared
from a Cxcl2 3=UTR cDNA ampliﬁed using RNA from Raw264.7 cells stimulated with LPS and a pair of PCR
primers (5= primer 5=-CTGGATCGTACCTGATGTGCCTC-3= and 3= primer 5-AACAGACGTTTTTATTTTTTGTT
ATTTGTAAAAATACATG-3=, bp 431 to 453 and 1044 to 1083 of the sequence under GenBank accession
no. NM_009140.2, respectively). The blots were quantitated using a PhosphorImager, and the probe-
bound mRNA volumes were obtained using Volume Quantiﬁcation (ImageQuant; Molecular Dynamics).
NanoString RNA analysis. Total cellular RNA from BMDM used in the RNA decay assays was analyzed
using the NanoString nCounter method (62) for a speciﬁc group of mRNAs. As is customary for this technique,
the observed counts were normalized by a series of internal spike-in controls and also for a set of
housekeeping controls that had been previously validated as stable during LPS actinomycin D treatment,
which represented a range of expression levels that spanned the expected experimental counts. GenBank
accession numbers for the transcripts presented in Fig. 7 are as follows: Cxcl1, NM_008176.1; Cxcl2,
NM_009140.2; Ier3, NM_133662.2; IL-10, NM_010548.1; Dusp, NM_010090.2; Socs3, NM_007707.2; Cd274,
NM_021893.3; Ptgs2, NM_011198.4; Zfp36 (TTP), NM_011756.3; and TNF, NM_013693.2.
Antibodies and Western blotting. At the end of the indicated reagent treatment periods, cultured
cell monolayers were scraped into ice-cold PBS and centrifuged at 600  g at 4°C for 5 min. The cell
pellets were rinsed quickly with ice-cold water containing 0.2 mM PMSF and 1 g/ml pepstatin A and
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then lysed on ice for 10 min in lysis buffer (50 mM Tris-HCl [pH 8.3], 150 mM NaCl, 1% NP-40, 5 mM EDTA,
5% glycerol, 2 mM dithiothreitol [DTT], 0.8 g/ml leupeptin, 0.2 mM PMSF, and 1 g/ml pepstatin A).
Lysates were centrifuged at 4°C for 15 min at 14,000  g. The supernatants were stored at 	80°C with
glycerol added to 20% (vol/vol). Equal amounts of protein (100 g/lane, or as indicated) were resolved
on 12% SDS-polyacrylamide gels and then transferred onto nitrocellulose membranes (GE Healthcare).
The membranes were preincubated in Tris-buffered saline with 0.5% Tween 20 (TBS-T) with 5% dry milk
for 1 h, followed by incubation with an antiserum against mouse TTP (63) at a 1:10,000 dilution in
TBS-T–5% dry milk at 4°C overnight. Blots were rinsed with TBS-T and incubated with a secondary
antibody conjugated to horseradish peroxidase (Bio-Rad) for 60 min at room temperature. After rinsing
with TBS-T, the blots were developed using enhanced chemiluminescence (ECL) (Thermo Scientiﬁc). The
blots were then stripped (Western blot stripping buffer; Thermo Scientiﬁc) and reprobed with an
antiactin antibody (Abcam) at a 1:50,000 dilution.
ELISA, cytokine/chemokine multiplex assay, and hematology. After the indicated LPS incubation
period, supernatants were collected from the BMDM cell cultures and centrifuged brieﬂy to remove
ﬂoating cells. Secreted TNF was determined by ELISA as described previously (28). The TNF protein
readout was corrected by the total volume of supernatant collected, as well as by the total RNA yield
from the indicated sample (i.e., TNF [pg/ml]  supernatant [ml]/total RNA [g]).
Supernatants of BMDM cell cultures used as agonists in MEF experiments were analyzed with a
mouse cytokine/chemokine magnetic bead panel (Milliplex MAP; EMD Millipore) on a Luminex-200
instrument.
Statistical analysis. Data are presented as means  SD. In the RNA decay experiments, the value
obtained after a period of stimulation (i.e., pretreatment references) was set at 1, with data from the
actinomycin D treatment time course expressed as a fraction of that original value. In some cases, the
time to decay (t50) of an assayed mRNA was deﬁned as the time at which the mRNA decreased to its 50%
level during the actinomycin D treatment time course, as analyzed by interpolation using nonlinear
regression (i.e., ﬁnding an X value [actinomycin D min] for Y at 0.5) (Prism 6; GraphPad). The differences
in t50 between the KI and the WT groups were compared (Prism 6; GraphPad) by two-tailed unpaired Student
t tests (with Welch’s correction) from 5 individual experiments (unless otherwise indicated); the difference
between the two groups was considered signiﬁcant when the test P value was 0.05. In analysis of the
NanoString assay results, the 2-way analysis of variance (ANOVA) with Sidak’s multiple-comparison test was
used to determine how an mRNA decay response was affected by two factors: (i) the two different genotypes
and (ii) the treatment with LPS followed by an actinomycin D time course. The difference in responses of the
two genotypes was considered signiﬁcant when the test P value was 0.05.
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